Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of REM sleep behavior disorder

Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of REM sleep behavior disorder

US Patent 10022355 · Granted Jul 17, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin2022
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin2022
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin2022
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin2018
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin2018
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin2018
Adjustable user interfaces with movable separators2018
Method for noribogaine treatment in patients on methadone2017
Methods and compositions for pre-screening patients for treatment with noribogai2017
Oral formulations of mitochondrially-targeted antioxidants and their preparation2017
Low dose noribogaine for treating nicotine addiction and preventing relapse of n2017
Use of ibogaine for the treatment of pain2017